Accendra Health Inc (ACH) financials
Accendra Health revenue and earnings by year
Accendra Health's revenue was $2.76 billion in the fiscal year to December 31, 2025, up 3.1% from the year before. Net income was -$1.10 billion, -39.8% of revenue. Since the fiscal year to December 31, 2016, revenue has shrunk 13.1% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.76 | 2.68 | 2.55 | 9.96 | 9.79 | 8.48 | 9.21 | 9.42 | 9.32 | 9.72 |
| Revenue growth | 3.1% | 5.0% | -74.4% | 1.7% | 15.4% | -7.9% | -2.2% | 1.1% | -4.2% | — |
| Gross profit | 1.29 | 1.28 | 1.22 | 1.83 | 1.51 | 1.28 | 1.13 | 1.07 | 1.17 | 1.19 |
| Gross margin | 46.7% | 47.8% | 47.7% | 18.3% | 15.5% | 15.1% | 12.3% | 11.4% | 12.6% | 12.2% |
| Operating income | 0.03 | -0.22 | 0.13 | 0.14 | 0.37 | 0.20 | 0.07 | -0.35 | 0.09 | 0.20 |
| Operating margin | 1.0% | -8.1% | 5.2% | 1.4% | 3.8% | 2.4% | 0.8% | -3.7% | 1.0% | 2.1% |
| Net income | -1.10 | -0.36 | -0.04 | 0.02 | 0.22 | 0.03 | -0.06 | -0.44 | 0.07 | 0.11 |
| Net margin | -39.8% | -13.5% | -1.6% | 0.2% | 2.3% | 0.4% | -0.7% | -4.6% | 0.8% | 1.1% |
| Diluted EPS | -$14.31 | -$4.73 | -$0.53 | $0.29 | $2.94 | $0.47 | -$1.02 | -$7.31 | $1.20 | $1.76 |
| Free cash flow | -0.23 | 0.05 | 0.63 | 0.21 | 0.07 | 0.28 | 0.11 | 0.05 | 0.01 | 0.16 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ACH in Markets.
How Accendra Health makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Diabetes Product | $199M | 32.4% |
| Sleep Therapy Product | $149M | 24.2% |
| Home Respiratory Therapy Product | $91.0M | 14.8% |
| Ostomy | $55.7M | 9.1% |
| Product & Service Other | $47.7M | 7.8% |
| Wound Care | $40.2M | 6.6% |
| Urology | $31.3M | 5.1% |
See also: ACH valuation and P/E history · ACH returns
No forecast, no recommendation. This page describes Accendra Health Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.